[Feasibility study of using bridging temporary permanent pacemaker in patients with high-degree atrioventricular block after TAVR]

Zhonghua Xin Xue Guan Bing Za Zhi. 2023 Jun 24;51(6):648-655. doi: 10.3760/cma.j.cn112148-20221116-00898.
[Article in Chinese]

Abstract

Objective: To determine the feasibility of using temporary permanent pacemaker (TPPM) in patients with high-degree atrioventricular block (AVB) after transcatheter aortic valve replacement (TAVR) as bridging strategy to reduce avoidable permanent pacemaker implantation. Methods: This is a prospective observational study. Consecutive patients undergoing TAVR at Beijing Anzhen Hospital and the First Affiliated Hospital of Zhengzhou University from August 2021 to February 2022 were screened. Patients with high-degree AVB and TPPM were included. Patients were followed up for 4 weeks with pacemaker interrogation at every week. The endpoint was the success rate of TPPM removal and free from permanent pacemaker at 1 month after TPPM. The criteria of removing TPPM was no indication of permanent pacing and no pacing signal in 12 lead electrocardiogram (EGG) and 24 hours dynamic EGG, meanwhile the last pacemaker interrogation indicated that ventricular pacing rate was 0. Routinely follow-up ECG was extended to 6 months after removal of TPPM. Results: Ten patients met the inclusion criteria for TPPM, aged (77.0±11.1) years, wirh 7 females. There were 7 patients with third-degree AVB, 1 patient with second-degree AVB, 2 patients with first degree AVB with PR interval>240 ms and LBBB with QRS duration>150 ms. TPPM were applied on the 10 patients for (35±7) days. Among 8 patients with high-degree AVB, 3 recovered to sinus rhythm, and 3 recovered to sinus rhythm with bundle branch block. The other 2 patients with persistent third-degree AVB received permanent pacemaker implantation. For the 2 patients with first-degree AVB and LBBB, PR interval shortened to within 200 ms. TPPM was successfully removed in 8 patients (8/10) at 1 month without permanent pacemaker implantation, of which 2 patients recovered within 24 hours after TAVR and 6 patients recovered 24 hours later after TAVR. No aggravation of conduction block or permanent pacemaker indication were observed in 8 patients during follow-up at 6 months. No procedure-related adverse events occurred in all patients. Conclusion: TPPM is reliable and safe to provide certain buffer time to distinguish whether a permanent pacemaker is necessary in patients with high-degree conduction block after TAVR.

目的: 评估经导管主动脉瓣置换术(TAVR)后传导阻滞患者应用过渡起搏器(TPPM)技术减少非必要永久起搏器植入的有效性和安全性。 方法: 本研究为前瞻性观察性研究。连续筛选2021年10月至2022年2月在北京安贞医院和郑州大学第一附属医院接受TAVR的所有患者,纳入TAVR术后出现传导阻滞并应用TPPM者。TPPM术后随访4周,每次随访时进行起搏器程控。研究终点为1个月时成功拔除TPPM,无需植入永久起搏器。成功拔除的标准为1个月时12导联心电图和24 h动态心电图无起搏信号,同时最后一次起搏器程控提示起搏比例为0。拔除TPPM后继续常规随访心电图至6个月。 结果: 共纳入10例患者,年龄(77.0±11.1)岁,女性7例。其中7例患者为三度房室传导阻滞(AVB),1例为二度AVB,2例为一度AVB(PR间期>240 ms)合并左束支传导阻滞(LBBB)(QRS间期>150 ms)。TPPM放置时间为(35±7)d。8例高度AVB患者中,3例恢复窦性心律,3例恢复窦性心律伴束支传导阻滞,2例仍存在三度AVB并接受了永久起搏器植入;2例一度AVB伴LBBB患者PR间期缩短至200 ms以内,仅遗留LBBB。8(8/10)例患者1个月时成功拔除TPPM无需植入永久起搏器,其中2例在TAVR术后24 h之内恢复窦性心律,6例在TAVR术后24 h之后恢复。随访6个月8例患者均未再出现传导阻滞加重。所有患者均未发生手术相关不良事件。 结论: TAVR术后传导阻滞患者应用TPPM是安全可靠的,可提供更长的缓冲时间来判断患者是否有必要植入永久起搏器。.

Publication types

  • Observational Study
  • English Abstract

MeSH terms

  • Atrioventricular Block* / therapy
  • Bundle-Branch Block
  • Feasibility Studies
  • Female
  • Humans
  • Pacemaker, Artificial*
  • Transcatheter Aortic Valve Replacement*